DBS CEO Tan Su Shan Ranks Sixth on Fortune 2026 Most Powerful Women List IREN Partners with Dell Technologies in 16 Billion AI Infrastructure Deal Escalating Geopolitical Tensions and Strong US Dollar Strain Asian Currency Reserves KeyBanc Maintains Overweight Rating on Microsoft Highlighting Cloud and AI Momentum ADP Report Shows Private Payrolls Rose by 109000 in April Exceeding Estimates Sensex Stocks with up to 40 Upside Potential Analysts Identify Key Names Apollo Global Management APO Q1 2026 Earnings EPS Misses by 05 Amid Mixed Market Signals Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 CRESY Q1 2026 Earnings Strong EPS of 61402 Drives Positive Market Reaction Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue GNLX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline LTC Q1 2026 Earnings EPS Misses Estimates as Revenue Data Unavailable ELPC Slips 126 Amid Resistance Test Key Levels for Companhia Paranaense de Energia SIFCO Industries Inc SIF Gains 18 as Shares Approach Key Resistance Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity Cellectis CLLS Slides 127 as Biotech Struggles to Hold Above Key Support Xerox Holdings XRX Surges 16 Can the Momentum Hold Above Key Resistance Wipro Sets June 5 Record Date for 15000 Crore Share Buyback Largest in Company History Jim Cramer Suggests Turnaround Strategy for Nike NKE Shares China Confirms Order for 200 Boeing Jets in First Major Deal in Nearly a Decade Signaling Renewed Aviation Cooperation Reliance Industries Boosts National Exchequer Contribution to Rs 216 Lakh Crore in FY26 Apimeds Posts 35M Q1 Deficit as Crypto Losses Weigh on Financials The Hidden Cost of Wealth Why Some Couples Pretend to Be Strapped for Cash Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Innovation Block Ovintiv Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline Mereo BioPharma MREO Tests Key Support at 031 After Modest Decline